1. Home
  2. SSBK vs VSTM Comparison

SSBK vs VSTM Comparison

Compare SSBK & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSBK
    SELLHOLDBUYas of 14 hours ago
  • VSTM
    SELLHOLDBUYas of 14 hours ago
  • Stock Information
  • Founded
  • SSBK 2007
  • VSTM 2010
  • Country
  • SSBK United States
  • VSTM United States
  • Employees
  • SSBK N/A
  • VSTM N/A
  • Industry
  • SSBK Commercial Banks
  • VSTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSBK Finance
  • VSTM Health Care
  • Exchange
  • SSBK Nasdaq
  • VSTM Nasdaq
  • Market Cap
  • SSBK N/A
  • VSTM 313.1M
  • IPO Year
  • SSBK 2021
  • VSTM 2012
  • Fundamental
  • Price
  • SSBK $36.32
  • VSTM $5.84
  • Analyst Decision
  • SSBK Buy
  • VSTM Strong Buy
  • Analyst Count
  • SSBK 1
  • VSTM 8
  • Target Price
  • SSBK $36.00
  • VSTM $13.00
  • AVG Volume (30 Days)
  • SSBK 29.4K
  • VSTM 930.9K
  • Earning Date
  • SSBK 04-21-2025
  • VSTM 03-20-2025
  • Dividend Yield
  • SSBK 1.00%
  • VSTM N/A
  • EPS Growth
  • SSBK 3.77
  • VSTM N/A
  • EPS
  • SSBK 3.67
  • VSTM N/A
  • Revenue
  • SSBK $94,140,000.00
  • VSTM $10,000,000.00
  • Revenue This Year
  • SSBK $19.67
  • VSTM N/A
  • Revenue Next Year
  • SSBK $7.74
  • VSTM $867.23
  • P/E Ratio
  • SSBK $9.73
  • VSTM N/A
  • Revenue Growth
  • SSBK 13.56
  • VSTM N/A
  • 52 Week Low
  • SSBK $22.13
  • VSTM $2.10
  • 52 Week High
  • SSBK $39.16
  • VSTM $13.52
  • Technical
  • Relative Strength Index (RSI)
  • SSBK 73.91
  • VSTM 41.38
  • Support Level
  • SSBK $32.06
  • VSTM $5.68
  • Resistance Level
  • SSBK $33.20
  • VSTM $6.33
  • Average True Range (ATR)
  • SSBK 0.91
  • VSTM 0.50
  • MACD
  • SSBK 0.48
  • VSTM -0.16
  • Stochastic Oscillator
  • SSBK 97.58
  • VSTM 18.62

Stock Price Comparison Chart: SSBK vs VSTM

SSBK
VSTM
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April051015202530354045505560SSBK VS VSTM

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use